Myopia Management in Calgary

MiYOSMART lenses by Hoya Vision Care work similarly to single-vision prescription lenses with a zone for helping focus. The difference with MiyoSmart lenses is that they feature a ring-shaped defocus area that specifically helps slow myopia progression, using a technology known as D.I.M.S. 

MiYOSMART lenses are impact resistant, anti-reflective, and come with UV protection to reduce the effect of sunlight on your child’s eyes. MiYOSMART lenses have been shown to slow myopia progression by 60%.

MiSight 1 day contact lenses have been an industry-leading myopia management technique for many years. Now, MiSight spectacle lenses are available for children as young as 6 years old.

MiSight spectacle lenses use Diffusion Optics Technology, which helps scatter light to reduce retinal contrast. After a 2 year study of children wearing MiSight spectacle lenses showed that they slow myopia progression by 59%.

ACUVUE® Abiliti™ contact lenses are the first daily wear lenses from Johnson & Johnson Vision specifically designed to slow the progression of myopia in children. These lenses use novel ring focus technology to help preserve your child’s vision while also providing unmatched comfort for all day wear.

MiSight 1 day is the first one-use disposable contact lens proven to slow myopia progression in children. In addition, MiSight 1 day lenses are designed to be easy to use for children who have not previously worn contact lenses before. Learn more about MiSight 1 day lenses.

Multi-focal contacts offer different corrective powers in different margins of the lens, allowing the wearer to see clearly at all distances. Studies have indicated that these lenses can be incredibly effective for myopia progression control, as they reduce the strain associated with close work.

ACUVUE® Abiliti contact lenses are the first daily wear lenses from Johnson & Johnson Vision specifically designed to slow the progression of myopia in children. These lenses use novel ring focus technology to help preserve your child’s vision while also providing unmatched comfort for all day wear.

ACUVUE’s targeted RingBoost technology focuses light in front of the retina but off the line of sight. This refocusing helps slow myopia progression more effectively by separating the need to provide vision quality myopia control simultaneously. This technique maximizes the strength of the treatment while providing effective vision correction.

MiSight 1 day is the first one-use disposable contact lens proven to slow myopia progression in children. In addition, MiSight 1 day lenses are designed to be easy to use for children who have not previously worn contact lenses before.

MiSight contact lenses are clinically proven to slow myopia progression by an average of 59% over a 3-year period. By providing vision correction and reducing eye elongation that causes myopia, MiSight provides lasting relief and long-term vision improvement.

Studies have shown that bifocal and multifocal eyeglasses can be helpful in managing myopia in children with certain eye-muscle positioning issues. This treatment option can be beneficial for children who prefer not to wear contact lenses or use eye drops. Talk to your optometrist about whether bifocals or multifocals are right for your child.

Atropine eye drops have shown to reduce the progression of myopia in some studies. Applied once a day, these eye drops help to slow the development of myopia. You can use atropine eye drops in tandem with other treatment methods depending on what your optometrist recommends.

Ortho-k or orthokeratology involves using a special kind of rigid contact lenses worn overnight. The lenses gently reshape the corneas while the patient is sleeping. Then, in the morning, the patient takes the ortho-k lenses out and enjoys clear vision at all distances for the entire day.

This treatment is not permanent, and the corneas will slowly revert to their natural shape over time. In addition, because it’s totally reversible, ortho-k doesn’t impact the possibility of laser eye surgery in the future.